Key result
Minimally invasive direct coronary artery bypass shows ~83% 5-year survival, matching the general population.
Why the study?
To evaluate the midterm follow-up and 5-year survival outcomes of the MIDCAB procedure compared with the survival of the general Swiss population.
Does the minimally invasive direct coronary artery bypass (MIDCAB) procedure provide comparable 5-year survival to the general population in patients with significant single-vessel disease of the LAD?
Observational (n=88)
No
Does the minimally invasive direct coronary artery bypass (MIDCAB) procedure provide comparable 5-year survival to the general population in patients with significant single-vessel disease of the LAD?
MIDCAB surgery for significant single-vessel LAD disease provides a 5-year survival rate comparable to that of an age- and gender-matched general population, with low perioperative morbidity.
No takes yet. Share an insight, caveat, or question.
May support MIDCAB for single-vessel LAD disease given population-comparable survival; leaves open randomized confirmation.
Reuthebuch et al. (2023) conducted an observational in Coronary artery disease (n=88). Minimally invasive direct coronary artery bypass (MIDCAB) vs. General Swiss population (age- and gender-matched) was evaluated on 5-year survival (95% CI 69-91). Minimally invasive direct coronary artery bypass resulted in an 83% 5-year survival rate, demonstrating an overlap with the survival range of an age- and gender-matched general Swiss population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: